News Zend_Feed_Writer 1.10.6 (http://framework.zend.com) http://www.imppc.org Dr Puig is taking over from Dr Miguel Àngel Gassull, director of the IGTP until now. Dr Gassull will now be managing the areas of Innovation and European Projects for the institute.

]]> Fri, 03 May 2013 17:28:21 -0400 http://www.imppc.org/imppc/news/42/the-endocrinologist-manel-puig-domingo-is-the-new-director-of-the-health-sciences-research-institute-of-the-germans-trias-i-pujol-foundation-igtp http://www.imppc.org/imppc/news/42/the-endocrinologist-manel-puig-domingo-is-the-new-director-of-the-health-sciences-research-institute-of-the-germans-trias-i-pujol-foundation-igtp Dr Puig is taking over from Dr Miguel Àngel Gassull, director of the IGTP until now. Dr Gassull will now be managing the areas of Innovation and European Projects for the institute.

]]> 0 The Buschbeck laboratory at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) have published two reviews on an important element of chromatin, the structure that packages DNA in cells and controls its function.

]]> Fri, 03 May 2013 16:40:38 -0400 http://www.imppc.org/imppc/news/39/two-new-reviews-published-by-the-buschbeck-laboratory http://www.imppc.org/imppc/news/39/two-new-reviews-published-by-the-buschbeck-laboratory The Buschbeck laboratory at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) have published two reviews on an important element of chromatin, the structure that packages DNA in cells and controls its function.

]]> 0 Josep Carreras, President of the Josep Carreras Leukaemia Research Institute (IJC) and the International Josep Carreras Foundation, Dídac Ramirez, Rector of the University of Barcelona (UB)and Albert Carreras, acting for the IJC, signed the agreement that will make a new campus possible.

]]> Fri, 03 May 2013 16:29:05 -0400 http://www.imppc.org/imppc/news/41/the-agreement-is-signed-for-the-construction-of-the-new-josep-carreras-institute-clinic-ub-campus http://www.imppc.org/imppc/news/41/the-agreement-is-signed-for-the-construction-of-the-new-josep-carreras-institute-clinic-ub-campus Josep Carreras, President of the Josep Carreras Leukaemia Research Institute (IJC) and the International Josep Carreras Foundation, Dídac Ramirez, Rector of the University of Barcelona (UB)and Albert Carreras, acting for the IJC, signed the agreement that will make a new campus possible.

]]> 0 The fourth annual conference has been the most successful yet; over 300 delegates attended over the two full days to hear 22 international speakers. Eduard Serra for the IMPPC organized the event with Gabriel Capellá, Ignacio Blanco and Conxi Lázaro of the Hereditary Cancer Program of the Catalan Institute of Oncology (ICO).

]]> Thu, 21 Mar 2013 12:12:36 -0400 http://www.imppc.org/imppc/news/37/iv-annual-conference-declared-a-great-success http://www.imppc.org/imppc/news/37/iv-annual-conference-declared-a-great-success The fourth annual conference has been the most successful yet; over 300 delegates attended over the two full days to hear 22 international speakers. Eduard Serra for the IMPPC organized the event with Gabriel Capellá, Ignacio Blanco and Conxi Lázaro of the Hereditary Cancer Program of the Catalan Institute of Oncology (ICO).

]]> 0 The unit for advanced genetic diagnosis for rare iron metabolism diseases (UDGAEMH) in the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) led by Dr. Mayka Sanchez has discovered a new mutation, the Badalona mutation, causing hereditary hyperferritinemia with cataracts syndrome (HHCS) in a Spanish family. This new mutation, along with previously discovered mutations, can be identified by genetic testing and allow the disease to be correctly diagnosed. Sometimes cases of HHCS have been confused with another genetic disease, Hereditary Hemochromatosis, which leads to the wrong treament being given to patients.

]]> Fri, 03 May 2013 16:33:07 -0400 http://www.imppc.org/imppc/news/38/the-badalona-mutation-discovered-by-imppc-researchers http://www.imppc.org/imppc/news/38/the-badalona-mutation-discovered-by-imppc-researchers The unit for advanced genetic diagnosis for rare iron metabolism diseases (UDGAEMH) in the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) led by Dr. Mayka Sanchez has discovered a new mutation, the Badalona mutation, causing hereditary hyperferritinemia with cataracts syndrome (HHCS) in a Spanish family. This new mutation, along with previously discovered mutations, can be identified by genetic testing and allow the disease to be correctly diagnosed. Sometimes cases of HHCS have been confused with another genetic disease, Hereditary Hemochromatosis, which leads to the wrong treament being given to patients.

]]> 0 Sònia Forcales of the Genetics and Epigenetics of Cancer group led by Manuel Perucho at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) has participated in a study published on-line in Nature today. The study was collaboration between researchers of the Sanford Burnham Institute for Medical Research and the Johns Hopkins University.

]]> Fri, 03 May 2013 13:11:36 -0400 http://www.imppc.org/imppc/news/40/a-new-disease-in-a-dish-model-for-hereditary-arvdc http://www.imppc.org/imppc/news/40/a-new-disease-in-a-dish-model-for-hereditary-arvdc Sònia Forcales of the Genetics and Epigenetics of Cancer group led by Manuel Perucho at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) has participated in a study published on-line in Nature today. The study was collaboration between researchers of the Sanford Burnham Institute for Medical Research and the Johns Hopkins University.

]]> 0 In a paper published today in Scientific Reports the Yamamoto group resolves a classic question in Glycobiology. The heterophilic Forssman glycolipid antigen has a structural similarity to the histo-blood group A antigen and the GBGT1 gene that codes for the Forssman glycolipid synthetase (FS) is evolutionarily related to the ABO gene. Dr Yamamoto is well known for his ground-breaking work on defining the genetics behind the ABO blood groups, and this current work clarifies the functioning of the second in the family of four closely related genes, which specifies the expression of the Forssman antigen.

]]> Wed, 19 Dec 2012 11:07:05 -0500 http://www.imppc.org/imppc/news/36/fumiichiro-yamamoto-and-the-abo-histo-blood-groups-and-cancer-laboratory-discover-the-molecular-genetic-basis-of-the-human-forssman-glycolipid-antigen-negativity http://www.imppc.org/imppc/news/36/fumiichiro-yamamoto-and-the-abo-histo-blood-groups-and-cancer-laboratory-discover-the-molecular-genetic-basis-of-the-human-forssman-glycolipid-antigen-negativity In a paper published today in Scientific Reports the Yamamoto group resolves a classic question in Glycobiology. The heterophilic Forssman glycolipid antigen has a structural similarity to the histo-blood group A antigen and the GBGT1 gene that codes for the Forssman glycolipid synthetase (FS) is evolutionarily related to the ABO gene. Dr Yamamoto is well known for his ground-breaking work on defining the genetics behind the ABO blood groups, and this current work clarifies the functioning of the second in the family of four closely related genes, which specifies the expression of the Forssman antigen.

]]> 0 Tanya Vavouri, Junior Group Leader at the IMPPC has just published her first paper for the IMPPC in Genome Biology. The paper, co-authored with Ben Lehner of the Genetic Systems group at the CRG, describes how the type of promoter in which transcription is initiated influences the chromatin of human genes.

]]> Mon, 29 Apr 2013 12:21:56 -0400 http://www.imppc.org/imppc/news/35/human-genes-with-cpg-island-promoters-have-a-distinct-transcription-associated-chromatin-organization http://www.imppc.org/imppc/news/35/human-genes-with-cpg-island-promoters-have-a-distinct-transcription-associated-chromatin-organization Tanya Vavouri, Junior Group Leader at the IMPPC has just published her first paper for the IMPPC in Genome Biology. The paper, co-authored with Ben Lehner of the Genetic Systems group at the CRG, describes how the type of promoter in which transcription is initiated influences the chromatin of human genes.

]]> 0 Wed, 05 Sep 2012 17:19:49 -0400 http://www.imppc.org/imppc/news/34/two-new-studies-by-the-genetic-variation-and-cancer-group-published http://www.imppc.org/imppc/news/34/two-new-studies-by-the-genetic-variation-and-cancer-group-published 0 The first stone of the new building of the Josep Carreras Leukemia Research Institute was laid on Saturday 7 July. The new building will be next to the IMPPC in the grounds of the Germans Trias i Pujol University Hospital.

]]> Thu, 06 Sep 2012 13:59:48 -0400 http://www.imppc.org/imppc/news/33/first-stone-laid-for-the-josep-carreras-leukaemia-research-institute http://www.imppc.org/imppc/news/33/first-stone-laid-for-the-josep-carreras-leukaemia-research-institute The first stone of the new building of the Josep Carreras Leukemia Research Institute was laid on Saturday 7 July. The new building will be next to the IMPPC in the grounds of the Germans Trias i Pujol University Hospital.

]]> 0